argenx SE (ARGX)
| Previous close | 550.00 |
| Open | 547.70 |
| Bid | 548.29 x 100 |
| Ask | 550.85 x 100 |
| Day's range | 546.71 - 551.97 |
| 52-week range | 327.73 - 554.74 |
| Volume | |
| Avg. volume | 330,577 |
| Market cap | 32.898B |
| Beta (5Y monthly) | 0.31 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Discovering argenx And 2 More Stocks That May Be Priced Below Estimated Value
As global markets react to China's robust stimulus measures, with U.S. stocks reaching record highs and European indices rebounding, investors are keenly observing the shifting economic landscape. In this context of heightened market activity and optimism around technological advancements, identifying undervalued stocks becomes crucial for those looking to capitalize on potential growth opportunities.
- Simply Wall St.
High Growth Tech Stocks To Watch In October 2024
As global markets react to China's robust stimulus measures, U.S. stocks have reached record highs, buoyed by optimism in technology sectors and AI demand, despite some mixed economic indicators such as consumer confidence and housing data. In this context of heightened market activity and evolving economic conditions, identifying high growth tech stocks involves looking for companies that are well-positioned to capitalize on technological advancements and shifts in consumer behavior driven...
- Investor's Business Daily
Biotech Leader Argenx In Buy Zone, Poised To Hit New Highs
Argenx stock is in a buy zone on the stock market today after a recent breakout and the biotech leader is poised to hit new highs.
